We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
A transfusion of blood and/or haemoderivatives is used to replace blood components that are vital for the survival of patients: blood cells, platelets and plasma, which cannot be replaced by other alternatives.
This treatment is indicated in patients who present a lack of essential blood components at any given time.
Transfusions carry a set of risks and the decision to undergo a transfusion should only be taken by a doctor after looking at the patient’s condition and taking an analysis and assessment of the situation. In this case, patients must always sign an authorisation document called an “informed consent” form.
Blood and its components are obtained from volunteers and altruistic donors. Before making a blood donation, donors must fill out a questionnaire about their state of health and, in addition, they must undergo a medical examination. All the blood components obtained are then analysed to make sure there are no diseases that can be transmitted through the blood.
Before making the transfusion, we must verify the blood derivative is compatible with the patient's blood. The physician in charge must assess the risk and benefits of treatment for the patient.
All the components are administered through a vein with a venous catheter.
Although blood transfusions are now very safe, some undesired side effects may occur:
The transmission of infectious diseases associated with blood is very unlikely nowadays. All donated blood is subject to prior analysis to find out about the blood group and prevent the transmission of infectious diseases such as syphilis, hepatitis B, hepatitis C, HIV, Chagas disease and infectious diseases
The transmission of infectious diseases associated with blood is very unlikely nowadays. All donated blood is subject to prior analysis to find out about the blood group and prevent the transmission of infectious diseases such as syphilis, hepatitis B, hepatitis C, HIV, Chagas disease and human T-lymphotrophic virus.
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.